Peroxisome proliferator-activated receptor γ agonist troglitazone inhibits high mobility group box 1 expression in endothelial cells via suppressing transcriptional activity of nuclear factor κb and activator protein 1

Shock

Volumn 36, Issue 3, 2011, Pages 228-234

  Gao, Min ^a   Hu, Zhangxue ^b   Zheng, Yingru ^b   Zeng, Yijun ^a   Shen, Xiaodong ^a   Zhong, Dan ^a   He, Fengtian ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

AP 1; endothelial cells; HMGB1; NF B; PPAR+

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; LUCIFERASE; MESSENGER RNA; TRANSCRIPTION FACTOR AP 1; TROGLITAZONE;

ARTICLE; CELL ACTIVITY; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ASSAY; ENZYME INHIBITION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INFLAMMATORY DISEASE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION;

BLOTTING, WESTERN; CELL LINE; CHROMANS; ENDOTHELIAL CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HMGB1 PROTEIN; HUMANS; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; NF-KAPPA B; PPAR GAMMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THIAZOLIDINEDIONES; TRANSCRIPTION FACTOR AP-1;

EID: 80051983637     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0b013e318225b29a     Document Type: Article

References (29)

1. Lotze MT, Tracey KJ: High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev 5:331-342, 2005. (Pubitemid 40516158)
2. Wang H, Ward MF, Sama AE: Novel HMGB1-inhibiting therapeutic agents for experimental sepsis. Shock 32:348-357, 2009.
3. Duan SZ, Usher MG, Mortensen RM: Peroxisome proliferatorYactivated receptor-gamma-mediated effects in the vasculature. Circ Res 102:283-294, 2008. (Pubitemid 351271648)
4. Wang N, Verna L, Chen NG, Chen J, Li H, Forman BM, Stemerman MB: Constitutive activation of peroxisome proliferatorYactivated receptor-gamma suppresses pro-inflammatory adhesion molecules in human vascular endothelial cells. J Biol Chem 277:34176-34181, 2002.
5. Reiterer G, Toborek M, Hennig B: Peroxisome proliferator activated receptors alpha and gamma require zinc for their anti-inflammatory properties in porcine vascular endothelial cells. J Nutr 134:1711-1715, 2004. (Pubitemid 38886559)
6. Pasceri V, Wu HD, Willerson JT, Yeh ET: Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferatorYactivated receptor-gamma activators. Circulation 101:235-238, 2000. (Pubitemid 30054148)
7. Liu Y, Zhu Y, Rannou F, Lee TS, Formentin K, Zeng L, Yuan X, Wang N, Chien S, Forman BM, et al.: Laminar flow activates peroxisome proliferatorYactivated receptor-gamma in vascular endothelial cells. Circulation 110:1128-1133, 2004. (Pubitemid 39319013)
8. HuangW, RhaGB, HanMJ, EumSY, Andras IE, Zhong Y, Hennig B, ToborekM: PPARalpha and PPARgamma effectively protect against HIV-induced inflammatory responses in brain endothelial cells. J Neurochem 107:497-509, 2008.
9. He F, Li J, Mu Y, Kuruba R, Ma Z, Wilson A, Alber S, Jiang Y, Stevens T, Watkins S, et al.: Downregulation of endothelin-1 by farnesoid X receptor in vascular endothelial cells. Circ Res 98:192-199, 2006.
10. van Oost BA, Edgell CJ, Hay CW, MacGillivray RT: Isolation of a human von Willebrand factor cDNA from the hybrid endothelial cell line EA.hy926. Biochem Cell Biol 64:699-705, 1986. (Pubitemid 16023960)
11. Ptasinska A, Wang S, Zhang J, Wesley RA, Danner RL: Nitric oxide activation of peroxisome proliferatorYactivated receptor gamma through a p38 MAPK signaling pathway. FASEB J 21:950-961, 2007. (Pubitemid 46348267)
12. Oh YJ, Youn JH, Ji Y, Lee SE, Lim KJ, Choi JE, Shin JS: HMGB1 is phosphorylated by classical protein kinase C and is secreted by a calcium-dependent mechanism. J Immunol 182:5800-5809, 2009.
13. Hagiwara S, Iwasaka H, Maeda H, Noguchi T: Landiolol, an ultrashort-acting beta1-adrenoceptor antagonist, has protective effects in an LPS-induced systemic inflammation model. Shock 31:515-520, 2009.
14. Straus DS, Glass CK: Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms. Trends Immunol 28:551-558, 2007. (Pubitemid 350101420)
15. Szanto A, Nagy L: The many faces of PPARgamma: anti-inflammatory by any means? Immunobiology 213:789-803, 2008.
16. Yang H, Ochani M, Li J, Qiang X, Tanovic M, Harris HE, Susarla SM, Ulloa L, Wang H, DiRaimo R, et al.: Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc Natl Acad Sci USA 101: 296-301, 2004. (Pubitemid 38084244)
17. Ellerman JE, Brown CK, de Vera M, Zeh HJ, Billiar T, Rubartelli A, Lotze MT: Masquerader: high mobility group box-1 and cancer. Clin Cancer Res 13: 2836-2848, 2007. (Pubitemid 46850704)
18. Li W, Sama AE, Wang H: Role of HMGB1 in cardiovascular diseases. Curr Opin Pharmacol 6:130-135, 2006. (Pubitemid 43362125)
19. Haraguchi T, Takasaki K, Naito T, Hayakawa K, Katsurabayashi S, Mishima K, Iwasaki K, Fujiwara M: Cerebroprotective action of telmisartan by inhibition of macrophages/microglia expressing HMGB1 via a peroxisome proliferatorYactivated receptor gamma-dependent mechanism. Neurosci Lett 464:151-155, 2009.
20. Bonaldi T, Talamo F, Scaffidi P, Ferrera D, Porto A, Bachi A, Rubartelli A, Agresti A, Bianchi ME: Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO J 22:5551-5560, 2003. (Pubitemid 37279964)
21. Youn JH, Shin JS: Nucleocytoplasmic shuttling of HMGB1 is regulated by phosphorylation that redirects it toward secretion. J Immunol 177: 7889-7897, 2006.
22. Huang D, Yang C, Wang Y, Liao Y, Huang K: PARP-1 suppresses adiponectin expression through poly(ADP-ribosyl)ation of PPAR gamma in cardiac fibroblasts. Cardiovasc Res 81:98-107, 2009.
23. Rodrigue-Way A, Demers A, Ong H, Tremblay A: A growth hormoneY releasing peptide promotes mitochondrial biogenesis and a fat burning-like phenotype through scavenger receptor CD36 in white adipocytes. Endocrinology 148:1009-1018, 2007.
24. Klune JR, Billiar TR, Tsung A: HMGB1 preconditioning: therapeutic application for a danger signal? J Leukoc Biol 83:558-563, 2008. (Pubitemid 351966865)
25. Palumbo R, Galvez BG, Pusterla T, De Marchis F, Cossu G, Marcu KB, Bianchi ME: Cells migrating to sites of tissue damage in response to the danger signal HMGB1 require NF-kappaB activation. J Cell Biol 179:33-40, 2007. (Pubitemid 47606681)
26. Remels AH, Langen RC, Gosker HR, Russell AP, Spaapen F, Voncken JW, Schrauwen P, Schols AM: PPARgamma inhibits NF-kappaBYdependent transcriptional activation in skeletal muscle. Am J Physiol Endocrinol Metab 297:E174-E183, 2009.
27. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK: The peroxisome proliferatorYactivated receptor-gamma is a negative regulator of macrophage activation. Nature 391:79-82, 1998. (Pubitemid 28079218)
28. Grau R, Iniguez MA, Fresno M: Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12, 14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferatorYactivated receptor-gamma-independent mechanism. Cancer Res 64:5162-5171, 2004. (Pubitemid 39006534)
29. Wu Q, Zhang W, Pwee KH, Kumar PP: Cloning and characterization of rice HMGB1 gene. Gene 312:103-109, 2003. (Pubitemid 37338115)